Thiem D Phan

Array ( [id] => 5620015 [patent_doc_number] => 20060189549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Chalcone derivatives and their use to treat diseases' [patent_app_type] => utility [patent_app_number] => 11/337207 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 113517 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189549.pdf [firstpage_image] =>[orig_patent_app_number] => 11337207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705795 [patent_doc_number] => 20060194843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => '3,4-Disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators' [patent_app_type] => utility [patent_app_number] => 11/336599 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52364 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194843.pdf [firstpage_image] =>[orig_patent_app_number] => 11336599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392458 [patent_doc_number] => 20090209771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'METHOD FOR PRODUCING PROPYLENE OXIDE' [patent_app_type] => utility [patent_app_number] => 11/813293 [patent_app_country] => US [patent_app_date] => 2006-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2790 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209771.pdf [firstpage_image] =>[orig_patent_app_number] => 11813293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5682953 [patent_doc_number] => 20060199223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Chemiluminescent compounds and their use' [patent_app_type] => utility [patent_app_number] => 11/326852 [patent_app_country] => US [patent_app_date] => 2006-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9345 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199223.pdf [firstpage_image] =>[orig_patent_app_number] => 11326852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694985 [patent_doc_number] => 20060155132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Method of making dorzolamide hydrochloride' [patent_app_type] => utility [patent_app_number] => 11/326719 [patent_app_country] => US [patent_app_date] => 2006-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6507 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20060155132.pdf [firstpage_image] =>[orig_patent_app_number] => 11326719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410678 [patent_doc_number] => 20090124577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Intermediate Compounds for the Preparation of an Angiotensin II Receptor Antagonist' [patent_app_type] => utility [patent_app_number] => 11/722640 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11648 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124577.pdf [firstpage_image] =>[orig_patent_app_number] => 11722640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995228 [patent_doc_number] => 20070010573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Methods and compositions for treating amyloid-related diseases' [patent_app_type] => utility [patent_app_number] => 11/316694 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80354 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010573.pdf [firstpage_image] =>[orig_patent_app_number] => 11316694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4478450 [patent_doc_number] => 07906645 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Heterocyclic compounds as ccr2b antagonists' [patent_app_type] => utility [patent_app_number] => 11/793606 [patent_app_country] => US [patent_app_date] => 2005-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68526 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906645.pdf [firstpage_image] =>[orig_patent_app_number] => 11793606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7811482 [patent_doc_number] => 08134013 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Amide compound and thrombopoietin receptor activator' [patent_app_type] => utility [patent_app_number] => 11/721786 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 170720 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/134/08134013.pdf [firstpage_image] =>[orig_patent_app_number] => 11721786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649805 [patent_doc_number] => 20060135540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'PPAR active compounds' [patent_app_type] => utility [patent_app_number] => 11/289781 [patent_app_country] => US [patent_app_date] => 2005-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27573 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135540.pdf [firstpage_image] =>[orig_patent_app_number] => 11289781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9844527 [patent_doc_number] => 08946444 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control' [patent_app_type] => utility [patent_app_number] => 11/720055 [patent_app_country] => US [patent_app_date] => 2005-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 27109 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11720055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 232973 [patent_doc_number] => 07598400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-06 [patent_title] => 'AMPO spin traps' [patent_app_type] => utility [patent_app_number] => 11/286682 [patent_app_country] => US [patent_app_date] => 2005-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 4051 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/598/07598400.pdf [firstpage_image] =>[orig_patent_app_number] => 11286682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632398 [patent_doc_number] => 20060148868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Zolmitriptan polymorphs' [patent_app_type] => utility [patent_app_number] => 11/284729 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3214 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148868.pdf [firstpage_image] =>[orig_patent_app_number] => 11284729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5638092 [patent_doc_number] => 20060069066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Glycogen synthase kinase-3 inhibitors' [patent_app_type] => utility [patent_app_number] => 11/280209 [patent_app_country] => US [patent_app_date] => 2005-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 46351 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069066.pdf [firstpage_image] =>[orig_patent_app_number] => 11280209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5805009 [patent_doc_number] => 20060091361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Isothiazolone-containing preservative having enhanced stability' [patent_app_type] => utility [patent_app_number] => 11/265627 [patent_app_country] => US [patent_app_date] => 2005-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2537 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20060091361.pdf [firstpage_image] =>[orig_patent_app_number] => 11265627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856961 [patent_doc_number] => 07375221 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-05-20 [patent_title] => 'Method for azidoaminotriazole, nitrosoguanazine, and related compounds' [patent_app_type] => utility [patent_app_number] => 11/268408 [patent_app_country] => US [patent_app_date] => 2005-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6918 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/375/07375221.pdf [firstpage_image] =>[orig_patent_app_number] => 11268408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5742746 [patent_doc_number] => 20060088471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Compounds for enzyme inhibition' [patent_app_type] => utility [patent_app_number] => 11/254541 [patent_app_country] => US [patent_app_date] => 2005-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20773 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088471.pdf [firstpage_image] =>[orig_patent_app_number] => 11254541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829224 [patent_doc_number] => 20060063812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Indole derivatives' [patent_app_type] => utility [patent_app_number] => 11/230356 [patent_app_country] => US [patent_app_date] => 2005-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19091 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063812.pdf [firstpage_image] =>[orig_patent_app_number] => 11230356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649861 [patent_doc_number] => 20060135596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Amorphous form of a drug' [patent_app_type] => utility [patent_app_number] => 11/229894 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8071 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135596.pdf [firstpage_image] =>[orig_patent_app_number] => 11229894 [rel_patent_id] =>[rel_patent_doc_number] =>)